Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
3.500
+0.070 (2.04%)
At close: Jul 28, 2026, 4:00 PM EDT
3.500
0.00 (0.00%)
After-hours: Jul 28, 2026, 4:00 PM EDT
Nephros Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Nephros stock has a consensus rating of "Buy" and an average price target of $6.00. The average 1-year stock price forecast is 71.43% higher than the current stock price, while the lowest is $4.00 (+14.29%) and the highest is $8.00 (+128.57%).
Price Target: $6.00 (+71.43%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Nephros stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Aug '25 | Nov '25 | Mar '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Northland Securities | Northland Securities | Hold Initiates $4 | Hold | Initiates | $4 | +14.29% | Jul 17, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $8 | Buy | Reiterates | $8 | +128.57% | May 9, 2026 |
Financial Forecast
Revenue This Year
20.92M
from 18.79M
Increased by 11.34%
Revenue Next Year
23.80M
from 20.92M
Increased by 13.79%
EPS This Year
0.04
from 0.11
Decreased by -63.64%
EPS Next Year
0.15
from 0.04
Increased by 262.50%
EPS and Forward PE are based on non-GAAP adjusted numbers.